A Phase IV Double-Blind Placebo-Controlled Randomized Clinical Trial Assessing the Effect of 2 month consumption of Vetal Laban Including Lactobacillus acidophilus NCFM on Functional Gastrointestinal Symptoms Among Subjects Fulfilling Rome III Criteria for A Phase IV, Randomized, double-blind, placebo-controlled study with parallel groups Irritable Bowel Syndrome

drug protocol number

IBS - 0920

drug sponsor

Almarai

drug study

Vetal Laban containing Lactobacillus acidophilus NCFM at 1.6 x 109 CFU per container

drug trial site

King Fahad Medical City (Riyadh)

drug status

Rejected

drug phase